Stay updated on CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.

Latest updates to the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page
- ChecktodayChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference4%
- Check8 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.8%
- Check15 days agoChange DetectedDifference2%
- Check22 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference2%
- Check29 days agoChange DetectedThe website has updated the intervention details to include verified information from May 2021, with the last known status as recruiting, while removing previous contact information and an older revision.SummaryDifference6%
- Check36 days agoChange DetectedDifference3%
Stay in the know with updates to CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLL1-CD33 cCAR in Hematologic Malignancies Clinical Trial page.